Two Cannabis Penny Stocks to Consider Buying

Here is why Canopy Rivers (TSXV:RIV) and one other small-cap cannabis stock could be great opportunities.

| More on:
Cannabis stocks have fallen.

Some cannabis companies have already made a few lucky investors rich. For instance, Canopy Growth Corp (TSX:WEED)(NYSE:CGC) was worth just a couple of dollars in early 2016, but the firm’s shares are now worth about $35 (at writing). You aren’t likely to find such returns in many places on equity markets, or anywhere else for that matter. There are currently dozens of cannabis stocks that are trading for a couple of bucks or so, but two that stand out are Canopy Growth’s spin off Canopy Rivers (TSXV:RIV) and Flowr Corp (TSXV:FLWR). Here is why. 

Diversified operations

Canopy Rivers is a bit of a venture capital firm that specializes in the cannabis market. The company was originally created to land potential lucrative investing opportunities for Canopy Growth. Given the bright future of the industry, more and more marijuana companies are being formed, and there is no shortage of would-be partners for Canopy Rivers. However, the majority of new ventures fail, which puts an enormous amount of pressure on the company. The firm’s deal team spends hours upon hours considering diverse options. According to Canopy Rivers’ CEO, Narbe Alexandrian, the company has reviewed over 1,500 pitches in the past year. 

Canopy Rivers’ portfolio of partners isn’t huge yet, which perhaps speaks to the company’s careful approach. The 18 investments the firm has made so far include companies that focus on the hemp cultivation and extraction business, others that make edibles and cannabis-infused beverages, and still others that focus on beauty products, and many more. That may be Canopy Rivers’ greatest strength: its diversification across the entire cannabis industry. While the fate of pure play marijuana companies is tied to a few segments of the market, Canopy’s wide-reaching operation means the firm is less likely to incur significant losses as a result of stagnant sales in any particular sectors of the market. 

Premium cannabis

Flowr Corp has a simple vision: to make premium cannabis accessible to as many people as possible. The firm’s strategy is to grow high-quality dried flower marijuana, which should allow the company to price its recreational products at a premium. In a market in which a supply glut risks dragging down sales and margins, Flowr Corp’s approach seems like a good idea. The company is also active in the medical segment of the market. Though Flowr Corp’s current production capacity isn’t impressive, the firm recently acquired the remaining shares of Holigen — a company in which it already had a 20% stake — in a cash and stock deal. This deal will allow Flowr Corp to reach a production capacity of about 500,000 kilograms when operating at full capacity, which should put the firm among the top companies in this category. If Flowr Corp can keep pricing its high-quality products at a healthy premium while increasing its production capacity, the company’s top line could continue growing at a nice clip. 

The bottom line

Both Canopy Rivers and Flowr Corp aren’t too far removed from “startup” status, but then again that’s true of much of the marijuana industry. Despite the risk involved, though, both companies could end up being winners in the long run. While it may be too early to pull the trigger, I would keep my eyes on them. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Prosper Junior Bakiny has no position in any of the stocks mentioned.

More on Cannabis Stocks

Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.
Cannabis Stocks

Canopy Growth: Is There Budding Potential in the Cannabis Market?

Canopy Growth stock hit 52-week lows recently on news of needing to re-file on its BIoSteel business, so what now?

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

What’s Happening With Cannabis Stocks in May 2023?

Cannabis stocks were up this week, as the market began to turn, but how long will it last, and is…

Read more »

Cannabis smoke
Cannabis Stocks

Are Cannabis Stocks a Good Buy in May 2023?

If you're going to buy cannabis stocks, these are pretty much the only two I would consider. Even so, you…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Aurora Cannabis: Time to Light Up Your Portfolio?

Here's my take on whether Aurora Cannabis (TSX:ACB) is worth adding to a growth portfolio right now, given its growth…

Read more »

Target. Stand out from the crowd
Tech Stocks

These Undervalued TSX Stocks Are a Bargain in May 2023

If you're willing to bet on a rebound, these are the three TSX stocks I would consider first as they…

Read more »

A cannabis plant grows.
Cannabis Stocks

Tilray Stock Is Scraping 52-Week Lows: Will it Bottom Out Soon?

Tilray (TSX:TLRY) stock remains down 53% in the last year, but when will this company hit the bottom and start…

Read more »

Medicinal research is conducted on cannabis.
Metals and Mining Stocks

2 Canadian Stocks That Are Simply Too Cheap to Avoid

These two Canadian stocks have sunk lower and lower, which is why now could be the right time for long-term…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

1 Marijuana Stock I’d Buy Over Aurora Cannabis

Explore a promising marijuana stock that outshines Aurora Cannabis. Unveil the investment opportunity to boost your cannabis portfolio.

Read more »